Life Sciences 360 – Details, episodes & analysis

Welcome to episode 060 of Life Sciences 360.

In this episode of Life Sciences 360, host Harsh Thakkar sits down with Dr. Robin Odegaard, a high-performance business psychologist and professional confidant, to discuss the hidden struggles that come with success. They dive deep into topics like imposter syndrome, self-sabotage, complex priorities, and the loneliness that often accompanies high achievement. Dr. Robin shares actionable strategies and insights from her extensive work with lawyers, biotech CEOs, neurosurgeons, and more.

Chapters:
00:00 - Introduction  
00:33 - The Voice in Your Head & Head Trash  
01:29 - Dr. Robin’s Journey into High-Performance Psychology  
02:48 - Understanding Self-Sabotage and How It Manifests  
05:10 - The Loneliness of Success: Why It’s “Lonely at the Top”  
07:23 - Techniques to Recognize and Combat Self-Sabotage  
11:22 - Managing Complex Priorities with the “Foresting Project”  
15:48 - Time Audits & Delegation for Effective Time Management  
18:41 - The Challenge of Letting Go for High Performers  
20:58 - Working with Diverse Clients: From Athletes to CEOs  
23:03 - Emotional State Management for Better Communication  
27:28 - The Isolation of Success & Who High Achievers Talk To  
33:47 - Final Thoughts & Advice for Listeners  
35:58 - Conclusion

Connect with Dr. Robin Odegaard:

- Website: (https://www.mentalmacgyver.com)  
- LinkedIn: (https://www.linkedin.com/in/robinodegaard)  
- YouTube: (https://www.youtube.com/@DrRobin)

Watch Next: 

Take Out the Head Trash | How to Fight the Demons Keeping You Awake at 3 a.m

(https://youtu.be/Kx12TTCoojg?si=BDsG4KLZOVMO71HW)

Don’t forget to like, share, and subscribe for more insightful conversations on achieving success in life sciences and beyond!

---

Links:

*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go! 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have. Have you implemented this into your operations yet? 
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

Thank you for watching and supporting our channel!

#HighPerformance #ImposterSyndrome #SelfSabotage #MentalHealth #ExecutiveCoaching #Productivity #MindsetMatters #SuccessMindset #Leadership #PersonalDevelopment #Psychology #Loneliness #HeadTrash #Entrepreneurship #LifeSciences360

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 059 of Life Sciences 360.

In this episode of Life Sciences 360, Harsh Thakkar is joined by John Finn, Chief Scientific Officer at Tome Biosciences. John shares his inspiring journey of overcoming challenges, like his stutter, while making groundbreaking strides in gene therapy. They dive deep into Tome’s unique technology, PGI (Programmable Genomic Integration), which is revolutionizing how large-scale gene insertions are done with pinpoint accuracy. Learn how Tome Biosciences is leading the charge in curing genetic disorders and advancing cell therapy with cutting-edge science.

Chapters:
00:00 - Introduction to the Episode
00:29 - The Vision Behind Gene Therapy
01:13 - John’s Journey and Challenges with Stuttering
03:14 - How Stuttering Shaped John's Career in Science
05:43 - Introduction to Tome Biosciences
07:02 - The Origins of Tome and Founding Vision
09:49 - Why Large-Scale Gene Editing Matters
14:12 - How Tome's PGI Technology Works
20:29 - What Sets Tome Apart in Gene Therapy
24:31 - Future Milestones for Tome Biosciences
30:49 - Overcoming Challenges in Genomic Integration
36:47 - The Power of Team Culture at Tome Biosciences
40:20 - Advice for Aspiring Scientists and Entrepreneurs
42:52 - Where to Connect with John Finn and Learn More About Tome

- Follow John Finn:

 *Linkedin - ( https://www.linkedin.com/in/jonathan-john-finn-8b3bb23/ )
 *Tome Bio Linkedin -  ( https://www.linkedin.com/company/tome-biosciences/ )
 * Tome Bio Website- ( https://tome.bio/ )

---
Links:

*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go! 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have. Have you implemented this into your operations yet? 
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

Thank you for watching and supporting our channel!


#GeneTherapy #LifeSciences #TomeBiosciences #GenomicIntegration #Biotechnology #CRISPR #PGI #GeneEditing #HealthcareInnovation #StutterAwareness #CellTherapy #PersonalizedMedicine

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 050 of Life Sciences 360.

In this episode, Harsh Thakkar chats with Tony Martignetti, a top leadership development voice on LinkedIn and an advisor to numerous tech and life sciences executives. Tony shares his insights on inspired leadership, the importance of investing in people, and how to unlock potential within teams. They also discuss the concept of flashpoints in both personal and organizational contexts and the value of embracing divergent thinking in the workplace.

Chapters:
00:00 Introduction to Tony Martignetti and Leadership Development
01:04 Advocating for Inspired Leadership
02:23 Influences: Henry Tamir and “No Rules, Rules” Book
04:37 Investing in People: Beyond Pedigree
06:19 Authentic Leadership: Bringing Your Whole Self to Work
09:40 The Core Model: Encouraging Authenticity in Teams
11:33 Identifying and Aligning Personal and Organizational Flashpoints
13:04 Overcoming Barriers: Personal Stories and Career Challenges
16:13 Flashpoints in Organizations: Examples and Insights
19:34 Embracing Divergent Thinking for Innovation
25:30 Convergent Hearts: Building Connection and Understanding
30:46 Practical Tips for Leaders to Foster Innovation and Growth
35:21 Specialist vs. Generalist: Expanding Skills and Knowledge
39:36 Key Takeaways: Expanding Vision and Narrowing Focus

-----
Links:

*Tony Martignetti LinkedIn (https://www.linkedin.com/in/tonymartignetti1/)
*Tony Martignetti Website (https://ipurposepartners.com/)
*Harsh Thakkar LinkedIn (https://www.linkedin.com/in/harshvthakkar/)
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 049 of Life Sciences 360.

In this episode of Life Sciences 360, host Harsh Thakkar welcomes Jesse Mendelsohn, Senior Vice President at Model N. Jesse delves into the intricacies of revenue optimization and compliance within the pharmaceutical industry. He shares insights on how Model N's platform aids pharmaceutical companies in navigating complex pricing, regulatory challenges, and government negotiations.

Chapters :
0:00 - Introduction
1:30 - Welcoming Jesse Mendelsohn
2:00 - Jesse's Journey with Model N
6:00 - Evolution of Pharma Pricing and Compliance
8:30 - Challenges in Commercial Contracting
12:00 - Regulatory Side of Pharma Pricing
14:30 - Impact of Government as a Major Drug Purchaser
16:00 - Inflation Reduction Act Overview
19:00 - Medicare's Right to Negotiate Drug Prices
21:00 - Aftershocks of the Inflation Reduction Act
23:30 - Key Takeaways for Pharma Executives
26:00 - Impact on Drug Development Strategy
28:00 - Generics and Biosimilars Market Impact
30:30 - Positive Outcomes of the Inflation Reduction Act
32:00 - What's Next for Model N
36:00 - Importance of Accurate Data in Pricing
38:30 - Closing Remarks and Connect with Jesse
-----
Links:

* Jesse Mendelsohn LinkedIn (https://www.linkedin.com/in/jessedm/)
* Model N LinkedIn (https://www.linkedin.com/company/modeln/)
* Model N website (https://www.modeln.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/  )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 048 of Life Sciences 360.

In this episode, Sharmeen discuss the current one-size-fits-all approach in healthcare and the need for precision dosing. Sharmeen explains how DoseMe platform simplifies complex dosing methods at the bedside, benefiting both clinicians and patients. Sharmeen also touch on the integration with electronic health records and the use of real-world data to improve dosing.

Shownotes :

00:00 Introduction
02:58 User Demographics
04:42 Integration with EHR
10:20 Therapeutic Areas
14:00 Bayesian Method
16:20 Real-time Data
20:20 Nerd Out on the Topic
25:00 AUC-guided Dosing
29:00 Implementation Process

-----
Links:

* Sharmeen Roy LinkedIn (https://www.linkedin.com/in/sharmeenroy/)
* DoseMe LinkedIn (https://www.linkedin.com/company/doseme-pty-ltd/ )
* DoseMe website (https://doseme-rx.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/  )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet? 
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

#PrecisionDosing #BayesianDosing #HealthcareInnovation #DoseMeRx #Pharmacology #ClinicalTrials #IndividualizedMedicine #BayesianMethods #HarshThakkar #SharmeenRoy

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 047 of Life Sciences 360.

In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben  highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies stay informed about clinical trials and changes in the industry. 

Watch the video to learn how AI can assist in making informed decisions in the life sciences field.

Chapters :
00:00 - Introduction
00:24 - AI in Decision-Making
00:45 - Welcome and Guest Introduction
01:00 - InThought Research and Infernesis
02:00 - Challenges in Clinical Trials
03:40 - InVision Technology Platform
06:36 - AI Integration in InVision
08:22 - Machine Learning and Natural Language Processing
13:20 - Case Study: Clinical Trial Data Analysis
17:56 - Privacy and Regulation in Healthcare
19:34 - AI and Job Security
24:21 -Practical Applications of AI
26:16 - Spire Bioadvisors
29:40 - Trends in Biotech and Drug Development
32:58 - Future of AI in Healthcare
37:28 - Ben's Personal Insights
39:12 - Closing Thoughts

----- 
Links:

* Ben Weintraub LinkedIn (https://www.linkedin.com/in/ben-weintraub-0566389/)
* inThought Research LinkedIn (https://www.linkedin.com/company/inthought-research/ )
* inThought Research website (https://inthought.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/  )
*Listen to this episode on the go! 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet? 
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#AIinHealthcare #ClinicalTrials #DrugDevelopment #LifeSciences360 #BiotechStartups #PersonalizedMedicine #GeneTherapy #MachineLearning #NaturalLanguageProcessing #HealthcareInnovation

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 046 of Life Sciences 360.

On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delve into topics such as manufacturing, strategy formation, and the impact of cell therapy on oncology. 

This episode provides valuable information for anyone interested in the field and invites viewers to explore the possibilities of this groundbreaking technology.

Show notes:

00:00 Introduction
02:40 Autologous Cell Therapies
04:40 Formation of CTMC
08:40 Recognition and Impact
11:48 Challenges in Cell Therapy Manufacturing
15:00 Acquisition of a Facility
17:20 Unexpected Growth
21:49 Houston's Support for Multi-Center Trials
27:52 Conceptualizing Virtual Manufacturing
34:20 Maintaining Focus and Vision

----- 
Links:
* Jason Bock LinkedIn ( https://www.linkedin.com/in/jason-b-bock/ )
* CTMC LinkedIn
(https://www.linkedin.com/company/celltherapymanufacturingcenter/)
*CTMC website (https://ctmc.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/)

*Listen to this episode on the go! 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

----- 

#Biotech #celltherapy  #MDAnderson #LifeSciences #CellManufacturing #CancerResearch #AdvancedTherapies #BiotechIndustry #MedicalResearch #InnovativeTherapies #BiotechPartnerships #BiotechCareer #Biopharmaceuticals #DigitalQuality #BiotechLeadership #IndustrialManufacturing #healthcareinnovation #MedicineMakers #Biologics #ClinicalResearch #CancerTreatment

For transcripts, check out the podcast website - www.lifesciencespod.com

Welcome to episode 045 of Life Sciences 360.

On this episode, Nagesh Nama and his team at XLM talk on why Gen.AI is essential in the software test world and share examples of its use in various industries, particularly in life sciences and manufacturing. They address the challenges faced by companies in adopting AI and provide solutions for integrating AI into existing systems.

Harsh and his guests discuss how AI can improve productivity, enhance quality assurance processes, and enable proactive decision-making. The conversation emphasizes the importance of having an AI strategy and encourages SMBs to embrace AI to gain a competitive advantage.

-----
Links:

* Nagesh Nama LinkedIn
* xLM LinkedIn
*xLM website
*Harsh Thakkar LinkedIn
*Would you rather watch this episode? Click here for the YouTube episode.


👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel Life Sciences 360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

----- 
Show Notes:

(0:00) Human vs. AI Diagnosis

(4:40) Using AI to Automate Clinical Trial Management Systems

(8:18) Challenges of AI adoption & Data Integrity 

(13:55) Affordable AI Validation Services for SMBs

(17:55) New Companies Add AI Features, Chat GPT Stays Ahead

(21:58) How To Increase Productivity & Improve Compliance 

(26:44) XLM's AI Powered Platform

(30:45) AI in Pharma 

(34:57) Using AI for Supply Chain Management

For transcripts, check out the podcast website - www.lifesciencespod.com

Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics.

Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenings.  He discusses the development of their innovative prostate cancer diagnostic test.

In Episode 044 of Life Sciences 360, Harsh and Arnon also emphasize the importance of asking the right questions in scientific research and the need for simple and actionable diagnostic tools in healthcare. They advise individuals to stay curious and interested in order to be productive and successful.

-----
Links:

*Arnon LinkedIn
*Cleveland Diagnostics
*Harsh Thakkar LinkedIn
*Would you rather watch on YouTube, Click HERE


👍 Like this video if you enjoy deep dives into healthcare innovations.
🔔 Subscribe to our channel Life Sciences 360 for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors and Leave us a Review.

----- 
Show Notes:

(00:00) Introduction and Background

(06:26) Choosing Cleveland as a Startup Location

(13:13) Balancing Over-Screening and Under-Treating in Cancer Diagnostics

(18:57) Proteins Involved in the Disease Process

(26:41) The Importance of a Solution that Fits the Final Application

(29:05) The Power of Curiosity and Interest in a Career

(31:18) Final Thoughts and Advice

For transcripts, check out the podcast website - www.lifesciencespod.com

With the market estimated to reach $11.5 billion by 2028. Clean Rooms on Demand is providing flexible and cost-effective solutions for biotech and pharma companies.

The benefits of using clean rooms on demand include avoiding the high capital outlay and ongoing operational expenses of building and maintaining their own facilities, as well as the flexibility to scale up or down as needed.

Join me in Episode 43 of Life Sciences 360, with Sarah Stevens, the President of Azzur Labs and Azzur Cleanrooms on Demand, part of Azzur Group

-----
Links:

*Sarah Stevens LinkedIn
*Azzur Group
*Harsh Thakkar LinkedIn
*Would you rather watch? Click here. 

----- 
Show Notes:

(0:00) The Growing Cleanroom Technology Market

(3:29) Benefits of Cleanrooms on Demand

(6:41) A broader view of biotech lab solutions

(9:02) Customer Case Studies and Segments

(12:22) Expansion and Future Plans of Azzur Labs

(14:29) Global Expansion and Strategic Vision

(16:47) Sarah Stevens' Personal Career Journey 

(21:26) The Azzur Culture and Team Dynamics

For transcripts, check out the podcast website - www.lifesciencespod.com